MedTrace Logo

Chat-based Support for Preventing Smoking Relapse

NCT04409496 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2021-03-04

No results posted yet for this study

Summary

This pilot trial aims to evaluate the effectiveness of chat-based instant messaging support in preventing smoking relapse in recent tobacco abstainers.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Chat-based instant messaging support

Subjects will receive personalised instant messaging support for 12 weeks after baseline, address the five problems that contributed to smoking relapse: (1) lack of support for cessation, (2) negative mood or depression, (3) strong or prolonged withdrawal symptoms, (4) weight gain, and (5) smoking lapses. Updated information about the negative effect of smoking on risk of COVID-19 infection and prognosis will also be delivered.

BEHAVIORAL

SMS message support

Subjects will receive regular SMS on generic smoking cessation for 3 months.

BEHAVIORAL

Self-help booklet

Subjects will receive a standard self-help booklet on smoking relapse prevention.

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Tzu Tsun Luk, PhD, RN · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-02
Primary Completion
2021-01-22
Completion
2021-01-22

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04409496 on ClinicalTrials.gov